Tech Company Financing Transactions

Fovea Pharmaceuticals Funding Round

Fovea Pharmaceuticals closed a $25 million Series A venture capital round on 11/7/2005. Backers included Sofinnova Ventures, Abingworth and Credit Agricole Private Equity.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

17 rue Moreau
Paris, 75012
France

Phone

+33 (0)1 44 16 42 42

Website

www.fovea-pharma.com

Email Address

[email protected]

Overview

Fovea is dedicated to the discovery and development of INNOVATION in products for ocular diseases (retinal degeneration, glaucoma, dry eye, allergy and inflammation).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bernard Gilly

        

Chief Financial Officer

Strategic Controller

        

Chief Medical Officer

Soraya Bekkali

        

Chief Operating Officer

Pierre Bélichard

        

VP - Operations

Gilles Litman

        

Browse more venture capital transactions:

Prev: 11/5/2005: Ascenta Therapeutics venture capital transaction
Next: 11/7/2005: NexTone Communications venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary